Industry: Service & Software
Published Date: 2025-09-06
Pages: 108 Pages
Report ld: 4952428
Request Sample
Customized Report
The global Custom Peptide CDMO Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
The North America Custom Peptide CDMO Services market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Custom Peptide CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Custom Peptide CDMO Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Custom Peptide CDMO Services market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-GMP Services in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Scientific Research in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Custom Peptide CDMO Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Peptide CDMO Services Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Custom Peptide CDMO Services Revenue Market Share by Region (2020-2025)
2.4 Global Custom Peptide CDMO Services Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Custom Peptide CDMO Services Market Size and Prospective (2020-2031)
2.5.2 Europe Custom Peptide CDMO Services Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Custom Peptide CDMO Services Market Size and Prospective (2020-2031)
2.5.4 Latin America Custom Peptide CDMO Services Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Custom Peptide CDMO Services Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Custom Peptide CDMO Services Historic Market Size by Type (2020-2025)
3.2 Global Custom Peptide CDMO Services Forecasted Market Size by Type (2026-2031)
3.3 Different Types Custom Peptide CDMO Services Representative Players
4 Breakdown Data by Application
4.1 Global Custom Peptide CDMO Services Historic Market Size by Application (2020-2025)
4.2 Global Custom Peptide CDMO Services Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Custom Peptide CDMO Services Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Custom Peptide CDMO Services Players by Revenue (2020-2025)
5.1.2 Global Custom Peptide CDMO Services Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Custom Peptide CDMO Services Revenue
5.4 Global Custom Peptide CDMO Services Market Concentration Analysis
5.4.1 Global Custom Peptide CDMO Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Custom Peptide CDMO Services Revenue in 2024
5.5 Global Key Players of Custom Peptide CDMO Services Head office and Area Served
5.6 Global Key Players of Custom Peptide CDMO Services, Product and Application
5.7 Global Key Players of Custom Peptide CDMO Services, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Custom Peptide CDMO Services Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Custom Peptide CDMO Services Market Size by Type (2020-2025)
6.1.2.2 North America Custom Peptide CDMO Services Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Custom Peptide CDMO Services Market Size by Application (2020-2025)
6.1.3.2 North America Custom Peptide CDMO Services Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Custom Peptide CDMO Services Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Custom Peptide CDMO Services Market Size by Type (2020-2025)
6.2.2.2 Europe Custom Peptide CDMO Services Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Custom Peptide CDMO Services Market Size by Application (2020-2025)
6.2.3.2 Europe Custom Peptide CDMO Services Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Custom Peptide CDMO Services Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Custom Peptide CDMO Services Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Custom Peptide CDMO Services Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Custom Peptide CDMO Services Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Custom Peptide CDMO Services Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Custom Peptide CDMO Services Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Custom Peptide CDMO Services Market Size by Type (2020-2025)
6.4.2.2 Latin America Custom Peptide CDMO Services Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Custom Peptide CDMO Services Market Size by Application (2020-2025)
6.4.3.2 Latin America Custom Peptide CDMO Services Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Custom Peptide CDMO Services Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Custom Peptide CDMO Services Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Custom Peptide CDMO Services Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Custom Peptide CDMO Services Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Custom Peptide CDMO Services Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Bachem
7.1.1 Bachem Company Details
7.1.2 Bachem Business Overview
7.1.3 Bachem Custom Peptide CDMO Services Introduction
7.1.4 Bachem Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.1.5 Bachem Recent Development
7.2 CordenPharma
7.2.1 CordenPharma Company Details
7.2.2 CordenPharma Business Overview
7.2.3 CordenPharma Custom Peptide CDMO Services Introduction
7.2.4 CordenPharma Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.2.5 CordenPharma Recent Development
7.3 PolyPeptide
7.3.1 PolyPeptide Company Details
7.3.2 PolyPeptide Business Overview
7.3.3 PolyPeptide Custom Peptide CDMO Services Introduction
7.3.4 PolyPeptide Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.3.5 PolyPeptide Recent Development
7.4 AmbioPharm
7.4.1 AmbioPharm Company Details
7.4.2 AmbioPharm Business Overview
7.4.3 AmbioPharm Custom Peptide CDMO Services Introduction
7.4.4 AmbioPharm Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.4.5 AmbioPharm Recent Development
7.5 Genscript
7.5.1 Genscript Company Details
7.5.2 Genscript Business Overview
7.5.3 Genscript Custom Peptide CDMO Services Introduction
7.5.4 Genscript Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.5.5 Genscript Recent Development
7.6 Thermo Fisher
7.6.1 Thermo Fisher Company Details
7.6.2 Thermo Fisher Business Overview
7.6.3 Thermo Fisher Custom Peptide CDMO Services Introduction
7.6.4 Thermo Fisher Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.6.5 Thermo Fisher Recent Development
7.7 USV Peptides
7.7.1 USV Peptides Company Details
7.7.2 USV Peptides Business Overview
7.7.3 USV Peptides Custom Peptide CDMO Services Introduction
7.7.4 USV Peptides Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.7.5 USV Peptides Recent Development
7.8 Bio Basic
7.8.1 Bio Basic Company Details
7.8.2 Bio Basic Business Overview
7.8.3 Bio Basic Custom Peptide CDMO Services Introduction
7.8.4 Bio Basic Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.8.5 Bio Basic Recent Development
7.9 ScinoPharm
7.9.1 ScinoPharm Company Details
7.9.2 ScinoPharm Business Overview
7.9.3 ScinoPharm Custom Peptide CDMO Services Introduction
7.9.4 ScinoPharm Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.9.5 ScinoPharm Recent Development
7.10 JPT
7.10.1 JPT Company Details
7.10.2 JPT Business Overview
7.10.3 JPT Custom Peptide CDMO Services Introduction
7.10.4 JPT Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.10.5 JPT Recent Development
7.11 CBL
7.11.1 CBL Company Details
7.11.2 CBL Business Overview
7.11.3 CBL Custom Peptide CDMO Services Introduction
7.11.4 CBL Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.11.5 CBL Recent Development
7.12 Piramal Pharma
7.12.1 Piramal Pharma Company Details
7.12.2 Piramal Pharma Business Overview
7.12.3 Piramal Pharma Custom Peptide CDMO Services Introduction
7.12.4 Piramal Pharma Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.12.5 Piramal Pharma Recent Development
7.13 CPC Scientific
7.13.1 CPC Scientific Company Details
7.13.2 CPC Scientific Business Overview
7.13.3 CPC Scientific Custom Peptide CDMO Services Introduction
7.13.4 CPC Scientific Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.13.5 CPC Scientific Recent Development
7.14 Creative Peptides
7.14.1 Creative Peptides Company Details
7.14.2 Creative Peptides Business Overview
7.14.3 Creative Peptides Custom Peptide CDMO Services Introduction
7.14.4 Creative Peptides Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.14.5 Creative Peptides Recent Development
7.15 Chinese Peptide Company
7.15.1 Chinese Peptide Company Company Details
7.15.2 Chinese Peptide Company Business Overview
7.15.3 Chinese Peptide Company Custom Peptide CDMO Services Introduction
7.15.4 Chinese Peptide Company Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.15.5 Chinese Peptide Company Recent Development
7.16 ChengDu ShengNuo Biotec
7.16.1 ChengDu ShengNuo Biotec Company Details
7.16.2 ChengDu ShengNuo Biotec Business Overview
7.16.3 ChengDu ShengNuo Biotec Custom Peptide CDMO Services Introduction
7.16.4 ChengDu ShengNuo Biotec Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.16.5 ChengDu ShengNuo Biotec Recent Development
7.17 AppTec Co., Ltd.
7.17.1 AppTec Co., Ltd. Company Details
7.17.2 AppTec Co., Ltd. Business Overview
7.17.3 AppTec Co., Ltd. Custom Peptide CDMO Services Introduction
7.17.4 AppTec Co., Ltd. Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.17.5 AppTec Co., Ltd. Recent Development
7.18 GL Biochem
7.18.1 GL Biochem Company Details
7.18.2 GL Biochem Business Overview
7.18.3 GL Biochem Custom Peptide CDMO Services Introduction
7.18.4 GL Biochem Revenue in Custom Peptide CDMO Services Business (2020-2025)
7.18.5 GL Biochem Recent Development
8 Custom Peptide CDMO Services Market Dynamics
8.1 Custom Peptide CDMO Services Industry Trends
8.2 Custom Peptide CDMO Services Market Drivers
8.3 Custom Peptide CDMO Services Market Challenges
8.4 Custom Peptide CDMO Services Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Custom Peptide CDMO Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 148
USD 4900.00
(Single User License)
The global Custom Peptide CDMO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 105
USD 4250.00
(Single User License)
The global market for Custom Peptide CDMO Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 122
USD 3950.00
(Single User License)
The global Custom Peptide CDMO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 126
USD 2900.00
(Single User License)
The global Custom Peptide CDMO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 159
USD 4900.00
(Single User License)
The global market for Custom Peptide CDMO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 127
USD 3950.00
(Single User License)
The global market for Custom Peptide CDMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 94
USD 2900.00
(Single User License)
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
Published Date: 2024-06-15
Pages: 126
USD 4350.00
(Single User License)
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
Published Date: 2024-06-15
Pages: 157
USD 4900.00
(Single User License)
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
Published Date: 2024-06-15
Pages: 99
USD 2900.00
(Single User License)
The global Custom Peptide CDMO Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 148
The global Custom Peptide CDMO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 105
The global market for Custom Peptide CDMO Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 122
The global Custom Peptide CDMO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 126
The global Custom Peptide CDMO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 159
The global market for Custom Peptide CDMO Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 127
The global market for Custom Peptide CDMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 94
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
Published: 2024-06-15
Pages: 126
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
Published: 2024-06-15
Pages: 157
Custom Peptide CDMO (Contract Development and Manufacturing Organization) services refer to the outsourcing of peptide synthesis, development, and manufacturing processes to specialized companies. These services are provided by organizations with expertise in peptide chemistry, production, and quality control, helping pharmaceutical companies, biotech firms, and research institutions develop and produce peptides for various applications.
Published: 2024-06-15
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now